Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

An overview of recent metastatic HER2 breast cancer trials

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 27.01.20
Views: 94
Rating:

Prof Sandra Swain - Georgetown University Medical Centre, Washington, USA

Prof Sandra Swain spoke to ecancer at the BGICC 2020 conference in Cairo, Egypt about metastatic HER2 breast cancer.

After reminding us of the results of the CLEOPATRA trial, she also outlines the excellent results from SABCS concerning trastuzumab deruxtecan.

Following this, Prof Swain outlines the HER2CLIMB trial which looks at patients with brain metastases.

 

Related videos

follow us

SIOG metastatic renal cell carcinoma


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation